Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08TFH
|
|||
| Former ID |
DNC013793
|
|||
| Drug Name |
Indan-2-ylcarbamic Acid Biphenyl-3-yl Ester
|
|||
| Synonyms |
CHEMBL485886; Indan-2-ylcarbamic Acid Biphenyl-3-yl Ester
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H19NO2
|
|||
| Canonical SMILES |
C1C(CC2=CC=CC=C21)NC(=O)OC3=CC=CC(=C3)C4=CC=CC=C4
|
|||
| InChI |
1S/C22H19NO2/c24-22(23-20-13-17-9-4-5-10-18(17)14-20)25-21-12-6-11-19(15-21)16-7-2-1-3-8-16/h1-12,15,20H,13-14H2,(H,23,24)
|
|||
| InChIKey |
UEEYQEMKIXZIGW-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.